Gupta Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$2.5M Buy
38,558
+7,229
+23% +$492K 0.59% 36
2015
Q4
$2.42M Sell
31,329
-2,469
-7% -$196K 0.61% 35
2015
Q3
$2.78M Buy
33,798
+1,600
+5% +$142K 0.68% 34
2015
Q2
$2.84M Buy
32,198
+2,137
+7% +$196K 0.7% 38
2015
Q1
$2.66M Buy
+30,061
New +$2.67M 0.78% 33

Other funds holding NVS

Gupta Wealth Management's NVS Position: Q1 2016 in Review

Gupta Wealth Management increased its Novartis (NVS) stake by 23% in Q1 2016, buying an estimated $492K and bringing the position to 38,558 shares worth $2.5M. The position accounts for 0.59% of the portfolio, ranked #36.

Gupta Wealth Management first reported a position in NVS in Q1 2015 and has held it in 5 quarters since. The position peaked at $2.84M in Q2 2015. 876 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

  • Gupta Wealth Management held 38,558 shares of Novartis worth $2.5M as of Q1 2016.
  • Gupta Wealth Management bought 7,229 Novartis shares in Q1 2016, an estimated $492K.
  • Novartis made up 0.59% of Gupta Wealth Management's portfolio in Q1 2016, its #36 holding.
  • Gupta Wealth Management first reported a position in Novartis in Q1 2015 and has held it in 5 quarters since.
  • Gupta Wealth Management's Novartis position peaked at $2.84M in Q2 2015.
  • 876 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.